IQVIA (IQV) Competitors

Bruker (NASDAQ:BRKR) and IQVIA (NYSE:IQV) are related companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, dividends, profitability, valuation, analyst recommendations, media sentiment, institutional ownership and earnings.

Do analysts prefer BRKR or IQV?

Bruker presently has a consensus target price of $51.30, suggesting a potential upside of 53.32%. IQVIA has a consensus target price of $228.62, suggesting a potential upside of 21.13%. Given Bruker's higher probable upside, equities research analysts plainly believe Bruker is more favorable than IQVIA.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bruker	0 Sell rating(s)	6 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.45
IQVIA	0 Sell rating(s)	6 Hold rating(s)	17 Buy rating(s)	0 Strong Buy rating(s)	2.74

Is BRKR or IQV more profitable?

IQVIA has a net margin of 7.88% compared to Bruker's net margin of 2.31%. IQVIA's return on equity of 30.05% beat Bruker's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bruker	2.31%	17.89%	5.38%
IQVIA	7.88%	30.05%	6.77%

Does the media favor BRKR or IQV?

In the previous week, IQVIA had 10 more articles in the media than Bruker. MarketBeat recorded 32 mentions for IQVIA and 22 mentions for Bruker. IQVIA's average media sentiment score of 1.26 beat Bruker's score of 0.93 indicating that IQVIA is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Bruker	11 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	2 Very Negative mention(s)	Positive
IQVIA	23 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Positive

Which has higher earnings and valuation, BRKR or IQV?

IQVIA has higher revenue and earnings than Bruker. IQVIA is trading at a lower price-to-earnings ratio than Bruker, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bruker	$3.37B	1.51	$113.10M	$0.52	64.35
IQVIA	$15.70B	2.04	$1.37B	$6.91	27.31

Do institutionals and insiders hold more shares of BRKR or IQV?

79.5% of Bruker shares are owned by institutional investors. Comparatively, 89.6% of IQVIA shares are owned by institutional investors. 27.3% of Bruker shares are owned by insiders. Comparatively, 1.6% of IQVIA shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Which has more volatility and risk, BRKR or IQV?

Bruker has a beta of 1.16, indicating that its stock price is 16% more volatile than the S&P 500. Comparatively, IQVIA has a beta of 1.3, indicating that its stock price is 30% more volatile than the S&P 500.

Summary

IQVIA beats Bruker on 13 of the 16 factors compared between the two stocks.